174 related articles for article (PubMed ID: 3220097)
1. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
3. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.
Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
J Pharm Sci; 1995 May; 84(5):634-9. PubMed ID: 7658357
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
Pace S; Longo A; Toon S; Rolan P; Evans AM
Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
Rebouche CJ
Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of L-carnitine.
Evans AM; Fornasini G
Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
[TBL] [Abstract][Full Text] [Related]
9. Fractional absorption of L-carnitine after oral administration in rats: evaluation of absorption site and dose dependency.
Matsuda K; Yuasa H; Watanabe J
Biol Pharm Bull; 1998 Jul; 21(7):752-5. PubMed ID: 9703262
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
[TBL] [Abstract][Full Text] [Related]
11. Oral and intravenous pharmacokinetics of milrinone in human volunteers.
Stroshane RM; Koss RF; Biddlecome CE; Luczkowec C; Edelson J
J Pharm Sci; 1984 Oct; 73(10):1438-41. PubMed ID: 6502494
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of intravenously administered carnitine in haemodialysed children.
Glöggler A; Bulla M; Fürst P
J Pharm Biomed Anal; 1990; 8(5):411-4. PubMed ID: 2081201
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
16. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
[TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolite kinetics of oral L-carnitine in humans.
Bain MA; Milne RW; Evans AM
J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
Roncari G; Ziegler WH; Guentert TW
Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
